Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899375 · ClinicalTrials.gov registry record · NA
Effect of Tissue Flossing on Pain,Function and Movement
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04899375: Completed NA study, sponsored by New York Institute of Technology.
NCT04899375 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04899375, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of the current investigation is to examine the effect of tissue-flossing on upper extremity, pain, strength and functional performance in subjects with musculoskeletal-related complaints of pain surrounding the elbow complex
Primary Outcome
The 100 millimeter VAS is a commonly employed self-completed scale for the assessment of pain in adults. The scale is scored using a ruler, by measuring the distance in millimetres, along a 100 millimetres line, from the anchor marked "no pain".
Interventions
- DEVICE Floss band
- DEVICE ACE bandage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-05-23 |
| Phase | NA |
What the finished NCT04899375 record still lists
NCT04899375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Floss band is the first listed.
NCT04899375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04899375 about?
NCT04899375 is a clinical study titled "Effect of Tissue Flossing on Pain,Function and Movement". The purpose of the current investigation is to examine the effect of tissue-flossing on upper extremity, pain, strength and functional performance in subjects with musculoskeletal-related complaints of pain surrounding the elbow complex
What is the current status of trial NCT04899375?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-09-01. Estimated completion is 2020-05-23.
What interventions are being tested in trial NCT04899375?
The interventions under investigation include: Floss band (DEVICE), ACE bandage (DEVICE).
Who is sponsoring clinical trial NCT04899375?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04899375's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI